GLIPIZIDE and ASTHENIA

Overview

ASTHENIA is the #11 most commonly reported adverse reaction for GLIPIZIDE, manufactured by Roerig. There are 2,113 FDA adverse event reports linking GLIPIZIDE to ASTHENIA. This represents approximately 1.8% of all 115,301 adverse event reports for this drug.

Patients taking GLIPIZIDE who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ASTHENIA is a less commonly reported adverse event for GLIPIZIDE, but still significant enough to appear in the safety profile.

Other Side Effects of GLIPIZIDE

In addition to asthenia, the following adverse reactions have been reported for GLIPIZIDE:

• BLOOD GLUCOSE INCREASED — 6,675 reports
• NAUSEA — 4,443 reports
• DRUG INEFFECTIVE — 3,505 reports
• DIARRHOEA — 3,262 reports
• FATIGUE — 2,995 reports
• WEIGHT DECREASED — 2,812 reports
• DIZZINESS — 2,439 reports
• DYSPNOEA — 2,403 reports
• BLOOD GLUCOSE DECREASED — 2,231 reports
• VOMITING — 2,166 reports

Other Drugs Associated with ASTHENIA

The following drugs have also been linked to asthenia in FDA adverse event reports:

Does GLIPIZIDE cause ASTHENIA?

ASTHENIA has been reported as an adverse event in 2,113 FDA reports for GLIPIZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ASTHENIA with GLIPIZIDE?

ASTHENIA accounts for approximately 1.8% of all adverse event reports for GLIPIZIDE, making it a notable side effect.

What should I do if I experience ASTHENIA while taking GLIPIZIDE?

If you experience asthenia while taking GLIPIZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages